At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06086 FANGZHOU JIANKE
Trading 03-12 13:48:08
1.390
+0.050
+3.73%
High1.420Low1.260Vol3.72M
Open1.340D1 Closing1.340Amplitude11.94%
Mkt Cap1.93BTradable Cap1.93BTotal Shares1.39B
T/O4.96MT/O Rate0.27%Tradable Shares1.39B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
FANGZHOU JIANKE (06086.HK) Sets 19 March 2026 Board Meeting to Review FY 2025 Results and Final Dividend
Bulletin Express  ·  03-09 17:23
FANGZHOU JIANKE (06086.HK) Sets 19 March 2026 Board Meeting to Review FY 2025 Results and Final Dividend
Fangzhou Inc. (06086) Publishes February 2026 Monthly Return, Issued Shares Increase by 45.18 Million
Bulletin Express  ·  03-02
Fangzhou Inc. (06086) Publishes February 2026 Monthly Return, Issued Shares Increase by 45.18 Million
Fangzhou Inc. and Youcare Pharmaceutical Group Form Strategic AI Chronic Care Alliance
Reuters  ·  02-28
Fangzhou Inc. and Youcare Pharmaceutical Group Form Strategic AI Chronic Care Alliance
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services
THOMSON REUTERS  ·  02-28
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services
Fangzhou Inc. Recognized for AI Healthcare Innovation at Guangdong Digital Economy Conference
Reuters  ·  02-10
Fangzhou Inc. Recognized for AI Healthcare Innovation at Guangdong Digital Economy Conference
Ark Health Shares Surge Over 5% in Morning Session on Fundraising for AI-Powered Chronic Disease Platform
Stock News  ·  02-06
Ark Health Shares Surge Over 5% in Morning Session on Fundraising for AI-Powered Chronic Disease Platform
Fangzhou Completes HK$150 Million Top-up Placement
MT Newswires Live  ·  02-03
Fangzhou Completes HK$150 Million Top-up Placement
FANGZHOU JIANKE Completes Placing of 45.181 Million Shares via Top-Up Placement, Nets Approximately HK$144.3 Million
Deep News  ·  02-03
FANGZHOU JIANKE Completes Placing of 45.181 Million Shares via Top-Up Placement, Nets Approximately HK$144.3 Million
FANGZHOU JIANKE (06086) Completes Placing of 45.181 Million Shares, Raises Approximately HK$144.3 Million Net
Stock News  ·  02-02
FANGZHOU JIANKE (06086) Completes Placing of 45.181 Million Shares, Raises Approximately HK$144.3 Million Net
Fangzhou Inc (06086) Reports Unchanged Issued Shares and Authorised Share Capital
Bulletin Express  ·  02-02
Fangzhou Inc (06086) Reports Unchanged Issued Shares and Authorised Share Capital
Fangzhou Forecasts 2025 Revenue Surge and First Full-Year Profit
Reuters  ·  01-27
Fangzhou Forecasts 2025 Revenue Surge and First Full-Year Profit
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
THOMSON REUTERS  ·  01-27
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
BUZZ-HK-listed Fangzhou drops most in 9 months on discounted share sale
Reuters  ·  01-27
BUZZ-HK-listed Fangzhou drops most in 9 months on discounted share sale
Press Release: Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
Dow Jones  ·  01-27
Press Release: Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
BRIEF-Fangzhou Inc To Place 45.2 Million Shares
Reuters  ·  01-27
BRIEF-Fangzhou Inc To Place 45.2 Million Shares
Fangzhou Inc. Announces Placing of Existing Shares and Top-Up Subscription
Reuters  ·  01-27
Fangzhou Inc. Announces Placing of Existing Shares and Top-Up Subscription
Fangzhou Inc - to Place 45.2 Mln Shares at HK$3.32 per Share
THOMSON REUTERS  ·  01-27
Fangzhou Inc - to Place 45.2 Mln Shares at HK$3.32 per Share
Citigroup: FANGZHOU JIANKE (06086) Profit Alert Meets Expectations; "Buy" Rating with HK$8.5 Target Price
Stock News  ·  01-26
Citigroup: FANGZHOU JIANKE (06086) Profit Alert Meets Expectations; "Buy" Rating with HK$8.5 Target Price
Fangzhou Expects Return to Profit in 2025 on Strong Revenue Growth; Shares Jump 40%
MT Newswires Live  ·  01-26
Fangzhou Expects Return to Profit in 2025 on Strong Revenue Growth; Shares Jump 40%
FANGZHOU JIANKE (06086.HK) Soars Over 35%
Deep News  ·  01-26
FANGZHOU JIANKE (06086.HK) Soars Over 35%

Introduction

Company Name.
FANGZHOU JIANKE
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.
Issue price:
--